检索结果 - Alejandro Navarro
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer 由 Todd M. Bauer, Alice T. Shaw, Melissa L. Johnson, Alejandro Navarro, Justin F. Gainor, Holger Thurm, Yazdi K. Pithavala, Antonello Abbattista, Gerson Peltz, Enriqueta Felip
出版 2020Artigo -
6
Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients 由 Pablo Martínez, Javier Hernández‐Losa, S. Cedrés, Josep Castellví, Alex Martínez‐Martí, N Tallada, Nuria Murtra-Garrell, Alejandro Navarro-Mendivill, Víctor Rodríguez-Freixinós, Mercedes Canela, Santiago Ramón y Cajal, Enriqueta Felip
出版 2013Artigo -
7
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer 由 Patricia Iranzo, Ana Callejo, J.D. Assaf, Gaspar Molina, D. López-Valbuena, David García-Illescas, Núria Pardo, Alejandro Navarro, Alex Martínez‐Martí, S. Cedrés, Caterina Carbonell, Joan Frigola, Ramon Amat, Enriqueta Felip
出版 2022Revisão -
8
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer 由 Shindo, Koji, Yu, Jun, Suenaga, Masaya, Fesharakizadeh, Shahriar, Tamura, Koji, Almario, Jose Alejandro Navarro, Brant, Aaron, Borges, Michael, Siddiqui, Abdulrehman, Datta, Lisa, Wolfgang, Christopher L., Hruban, Ralph H., Klein, Alison Patricia, Goggins, Michael
出版 2017Text -
9
ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment 由 Santiago Ponce, S. Cedrés, Charles Ricordel, Nicolás Isambert, Santiago Viteri, Mercedes Herrera, Alex Martínez‐Martí, Alejandro Navarro, Mathieu Léderlin, Xavier Serres, Jon Zugazagoitia, Sylvia Vetrhus, Magnus Jäderberg, Thomas B. Hansen, Victor Levitsky, Luis Paz‐Ares
出版 2023Artigo -
10
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial 由 Alice T. Shaw, Enriqueta Felip, Todd M. Bauer, Benjamin Besse, Alejandro Navarro, Sophie Postel‐Vinay, Justin F. Gainor, Melissa L. Johnson, Jörg Dietrich, Leonard P. James, Jill S. Clancy, Joseph Chen, Jean‐François Martini, Antonello Abbattista, Benjamin Solomon
出版 2017Artigo -
11
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal pap... 由 Yu, Jun, Sadakari, Yoshihiko, Shindo, Koji, Suenaga, Masaya, Brant, Aaron, Almario, Jose Alejandro Navarro, Borges, Michael, Barkley, Thomas, Fesharakizadeh, Shahriar, Ford, Madeline, Hruban, Ralph H, Shin, Eun Ji, Lennon, Anne Marie, Canto, Marcia Irene, Goggins, Michael
出版 2017Text -
12
Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L... 由 Taofeek K. Owonikoko, H.R. Kim, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, J.S. Lee, Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Justin Fairchild, Christine Baudelet, K. Park
出版 2019Artigo -
13
1733P Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p) 由 S. Cedrés, J.D. Assaf, Purificación Gómez, Ana Pérez, Nuria Pardo Aranda, Alejandro Navarro, Alex Martínez‐Martí, D.H. Marmolejo Castaneda, M.A. Rezqallah Aron, Anna Pedrola, Javier Gonzalo‐Ruiz, Joan Frigola, Caterina Carbonell, Ramon Amat, Rodrigo Dienstmann, Enriqueta Felip
出版 2021Artigo -
14
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma 由 Aleix Prat, Alejandro Navarro, Laia Paré, Noemı́ Reguart, Patricia Galván, Tomás Pascual, Alex Martínez‐Martí, Paolo Nucíforo, Laura Comerma, Lluçia Alós, Núria Pardo, S. Cedrés, Cheng Fan, Joel S. Parker, Lydia Gaba, Iván Victoria, Núria Viñolas, Ana Vivancos, Ana Arance, Enriqueta Felip
出版 2017Artigo -
15
DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC) 由 Alex Martínez‐Martí, Enriqueta Felip, Judit Matito, Elisabetta Mereu, Alejandro Navarro, S. Cedrés, Núria Pardo, A. Martinez de Castro, Jordi Remón, Josep M. Miquel, Amy Guillaumet-Adkins, Ernest Nadal, Gustavo Rodríguez-Esteban, Oriol Arqués, Roberta Fasani, Paolo Nucíforo, Holger Heyn, Alberto Villanueva, Héctor G. Pálmer, Ana Vivancos
出版 2017Artigo -
16
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study 由 Charles M. Rudin, Mark M. Awad, Alejandro Navarro, Maya Gottfried, Solange Peters, Tibor Csőszi, Parneet Cheema, Delvys Rodríguez‐Abreu, Mirjana Wollner, James Chih‐Hsin Yang, Julien Mazières, F. Orlandi, Alexander Luft, Mahmut Gümüş, Terufumi Kato, Gregory P. Kalemkerian, Yiwen Luo, Victoria Ebiana, M. Catherine Pietanza, Hye Ryun Kim
出版 2020Artigo -
17
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer 由 Charles M. Rudin, Stephen V. Liu, Ross A. Soo, Shun Lü, Min Hee Hong, Jong Seok Lee, Maciej Bryl, Daphne W. Dumoulin, Achim Rittmeyer, Chao‐Hua Chiu, Özgür Özyılkan, Melissa L. Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S. Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond D. Meng, Martin Reck
出版 2023Artigo -
18
Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease 由 Víctor Marcos‐Garcés, José Gavara, José V. Monmeneu, María P. López‐Lereu, María José Bosch, Pilar Merlos, N Pérez, César Ríos‐Navarro, Elena de Dios, Clara Bonanad, Paolo Racugno, Alejandro Navarro, Bruno Ventura Pérez, Jose Aguilar Botella, Silvia Mastrolembo Ventura, Luis Mainar, Joaquim Cànoves, Mauricio Pellicer, David Moratal, Gema Miñana, Julio Núñez, Francisco J. Chorro, Vicente Bodı́
出版 2020Artigo -
19
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 由 Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, Jong Seok Lee, Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Carlos H. Barrios, Laurent Greillier, Sofia Baka, Miten Patel, Wen Lin, Giovanni Selvaggi, Christine Baudelet, Jonathan Baden, Dimple Pandya, Parul Doshi, Hye Ryun Kim
出版 2021Artigo -
20
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, control... 由 Michael Thomas, Santiago Ponce-Aix, Alejandro Navarro, Jorge Riera‐Knorrenschild, Manuel Schmidt, Emanuelly Varea Maria Wiegert, K. Kapp, B. Wittig, Claudia Mauri, M. Dómine Gómez, Jens Kollmeier, Parvis Sadjadian, K.-P. Fröhling, RM Huber, M. Wolf, Georg Pall, Veerle Surmont, Leon Bosquée, Paul Germonpré, W. Brückl, C. Grah, Christian Herzmann, Rumo Leistner, Andreas Meyer, Lothar Müller, Oliver Schmalz, Christian W. Scholz, Michael Schröder, Monika Serke, Claas Wesseler, Christian Brandts, Hans‐Georg Kopp, Wolfgang Blau, Frank Griesinger, M.R. García Campelo, Yolanda García García, Jose M. Pérez
出版 2018Artigo
相关主题
Internal medicine
Medicine
Oncology
Cancer
Lung cancer
Chemotherapy
Immunotherapy
Pathology
Clinical endpoint
Confidence interval
Environmental health
Gastroenterology
Hazard ratio
Population
Randomized controlled trial
Adenocarcinoma
Adverse effect
Biology
Cancer research
Cisplatin
Immune system
Immunohistochemistry
Immunology
Ipilimumab
Malignant pleural effusion
Nivolumab
Pembrolizumab
Surgery
ALK inhibitor
Alternative medicine